DE602004006536D1 - Bekämpfng von parasiten in tieren durch anwendung von imidazoä1,2-büpyridazinderivaten - Google Patents

Bekämpfng von parasiten in tieren durch anwendung von imidazoä1,2-büpyridazinderivaten

Info

Publication number
DE602004006536D1
DE602004006536D1 DE602004006536T DE602004006536T DE602004006536D1 DE 602004006536 D1 DE602004006536 D1 DE 602004006536D1 DE 602004006536 T DE602004006536 T DE 602004006536T DE 602004006536 T DE602004006536 T DE 602004006536T DE 602004006536 D1 DE602004006536 D1 DE 602004006536D1
Authority
DE
Germany
Prior art keywords
animals
imidazoe2
büpyridazine
derivatives
applying
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602004006536T
Other languages
English (en)
Other versions
DE602004006536T2 (de
Inventor
Kevin N Winzenberg
Craig L Francis
David G Sawutz
Ashit Ganguly
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MSD International Holdings GmbH
Original Assignee
Schering Plough Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Plough Ltd filed Critical Schering Plough Ltd
Publication of DE602004006536D1 publication Critical patent/DE602004006536D1/de
Application granted granted Critical
Publication of DE602004006536T2 publication Critical patent/DE602004006536T2/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/5025—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
DE602004006536T 2003-12-31 2004-12-22 Bekämpfng von parasiten in tieren durch anwendung von imidazoä1,2-büpyridazinderivaten Active DE602004006536T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US53372903P 2003-12-31 2003-12-31
US533729P 2003-12-31
PCT/US2004/043402 WO2005066177A1 (en) 2003-12-31 2004-12-22 Control of parasites in animals by the use of imidazo[1,2-b]pyridazine derivatives

Publications (2)

Publication Number Publication Date
DE602004006536D1 true DE602004006536D1 (de) 2007-06-28
DE602004006536T2 DE602004006536T2 (de) 2008-01-31

Family

ID=34748949

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004006536T Active DE602004006536T2 (de) 2003-12-31 2004-12-22 Bekämpfng von parasiten in tieren durch anwendung von imidazoä1,2-büpyridazinderivaten

Country Status (16)

Country Link
US (1) US7759349B2 (de)
EP (1) EP1699799B1 (de)
JP (1) JP4758909B2 (de)
KR (1) KR20060110344A (de)
CN (1) CN100582108C (de)
AT (1) ATE362475T1 (de)
AU (1) AU2004312506B2 (de)
BR (1) BRPI0418328A (de)
CA (1) CA2551867C (de)
DE (1) DE602004006536T2 (de)
ES (1) ES2285565T3 (de)
HK (1) HK1091207A1 (de)
NZ (1) NZ548098A (de)
PL (1) PL380764A1 (de)
WO (1) WO2005066177A1 (de)
ZA (1) ZA200605299B (de)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7943160B2 (en) * 2002-05-09 2011-05-17 Scimetrics Limited Corp. Pest control methods
MX2007003378A (es) 2004-09-23 2007-05-10 Schering Plough Ltd Control de parasitos en animales mediante el uso de nuevos derivados de trifluorometansulfonanilida oxima eter.
WO2006055565A2 (en) 2004-11-19 2006-05-26 Schering-Plough Ltd. Control of parasites in animals by the use of parasiticidal 2-phenyl-3-(1h-pyrrol-2-yl) acrylonitrile derivatives
CA2594325A1 (en) * 2004-12-28 2006-07-06 Takeda Pharmaceutical Company Limited Condensed imidazole compound and use thereof
AR054380A1 (es) * 2005-06-09 2007-06-20 Schering Plough Ltd Control de parasitos en animales con derivados de n- ((feniloxi) fenil) -1,1,1-trifluorometansulfonamida y de n-(fenilsulfanil) fenil) -1,1,1-trifluorometansulfonamida
US7750000B2 (en) 2005-09-02 2010-07-06 Bayer Schering Pharma Ag Substituted imidazo[1,2b]pyridazines as kinase inhibitors, their preparation and use as medicaments
DE102005042742A1 (de) * 2005-09-02 2007-03-08 Schering Ag Substituierte Imidazo[1,2b]pyridazine als Kinase-Inhibitoren, deren Herstellung und Verwendung als Arzneimittel
US8119667B2 (en) * 2005-12-29 2012-02-21 Schering-Plough Animal Health Corporation Carbonates of fenicol antibiotics
TW200803903A (en) * 2006-04-28 2008-01-16 Nihon Mediphysics Co Ltd Novel compound having affinity to amyloid
EP2019103B1 (de) * 2006-05-19 2011-11-30 Nihon Medi-Physics Co., Ltd. Verbindung mit affinität zu amyloid
EP2042501B1 (de) * 2006-06-21 2017-04-12 Nihon Medi-Physics Co., Ltd. Verbindung mit affinität zu amyloid
DE102006029447A1 (de) * 2006-06-21 2007-12-27 Bayer Schering Pharma Ag Oxo-substituierte Imidazo[1,2b]pyridazine, deren Herstellung und Verwendung als Arzneimittel
TW200817409A (en) 2006-08-04 2008-04-16 Takeda Pharmaceutical Fused heterocyclic derivative and use thereof
US8207189B2 (en) * 2006-11-30 2012-06-26 Nihon Medi-Physics Co., Ltd. Compound having affinity for amyloid
EP2091909A1 (de) * 2006-12-13 2009-08-26 Schering-Plough Ltd. Wasserlösliche florfenicol-prodrugs und analoga
CA2672795A1 (en) * 2006-12-13 2008-06-26 Schering-Plough Ltd. Water-soluble prodrugs of chloramphenicol, thiamphenicol, and analogs thereof
WO2008072682A1 (ja) * 2006-12-15 2008-06-19 Daiichi Sankyo Company, Limited イミダゾ［１，２－ｂ］ピリダジン誘導体
TWI406674B (zh) 2007-02-13 2013-09-01 Nihon Mediphysics Co Ltd Method for manufacturing diagnostic radiographic diagnostic agents
WO2008133192A1 (ja) * 2007-04-19 2008-11-06 Takeda Pharmaceutical Company Limited 縮合イミダゾール化合物およびその用途
TWI430995B (zh) 2007-06-26 2014-03-21 Du Pont 萘異唑啉無脊椎有害動物控制劑
BRPI0810929B8 (pt) 2007-06-27 2022-12-06 Du Pont uso de um composto de fórmula 1
ES2375425T3 (es) * 2007-07-26 2012-02-29 Novartis Ag Compuestos org�?nicos.
TWI556741B (zh) 2007-08-17 2016-11-11 英特威特國際股份有限公司 異唑啉組成物及其作為抗寄生蟲藥上的應用
AU2008314870A1 (en) * 2007-10-24 2009-04-30 Nihon Medi-Physics Co., Ltd. Novel compound having affinity for amyloid
WO2009057576A1 (ja) * 2007-10-30 2009-05-07 Nihon Medi-Physics Co., Ltd. 新規アミロイド親和性化合物の使用及び製造方法
KR20100101577A (ko) * 2007-10-30 2010-09-17 니혼 메디피직스 가부시키가이샤 신규 아밀로이드 친화성 화합물의 사용 및 제조 방법
US7868001B2 (en) 2007-11-02 2011-01-11 Hutchison Medipharma Enterprises Limited Cytokine inhibitors
TWI491610B (zh) * 2008-10-09 2015-07-11 必治妥美雅史谷比公司 作為激酶抑制劑之咪唑并嗒腈
UA110924C2 (uk) 2009-08-05 2016-03-10 Е. І. Дю Пон Де Немур Енд Компані Мезоіонні пестициди
BR112012002524A2 (pt) 2009-08-05 2019-09-24 Du Pont "composto de fórmula, composição, composição para proteger um animal de uma praga parasítica de invertebrados, métodos para controlar uma praga invertebrada e semente tratada"
BR112012002519A2 (pt) 2009-08-05 2019-09-24 Du Pont "pesticidas mesoiônicos"
US20120295931A1 (en) 2010-02-05 2012-11-22 Lutz Juergen Spiroindoline compounds for use as anthelminthics
BR112013006953A2 (pt) 2010-09-29 2016-07-26 Intervet Int Bv composto, composições farmacêutica e anti-helmíntica, uso de um composto, kit, e, método de tratamento de uma doença
CN105294549B (zh) 2010-09-29 2017-12-26 英特维特国际股份有限公司 N‑杂芳基化合物
WO2012087630A1 (en) 2010-12-20 2012-06-28 E.I. Du Pont De Nemours And Company Pyridine and pyrimidine compounds for controlling invertebrate
TWI617559B (zh) * 2010-12-22 2018-03-11 江蘇恆瑞醫藥股份有限公司 ２－芳基咪唑并［１，２－ｂ］嗒．２－苯基咪唑并［１，２－ａ］吡啶，和２－苯基咪唑并［１，２－ａ］吡衍生物
CN103619818A (zh) 2011-06-20 2014-03-05 纳幕尔杜邦公司 用于治疗蠕虫感染的杂环化合物
US9096599B2 (en) 2011-08-04 2015-08-04 Intervet Inc. Spiroindoline compounds
BR112014012759A8 (pt) 2011-11-28 2017-06-20 Du Pont composto, composição e método para tratamento
WO2013144179A1 (en) 2012-03-28 2013-10-03 Intervet International B.V. Heteroaryl compounds with a-cyclic bridging unit
US9260441B2 (en) 2012-03-28 2016-02-16 Intervet Inc. Heteroaryl compounds with cyclic bridging unit
WO2013158422A1 (en) 2012-04-17 2013-10-24 E. I. Du Pont De Nemours And Company Heterocyclic compounds for controlling invertebrate pests
WO2014099837A1 (en) 2012-12-18 2014-06-26 E. I. Du Pont De Nemours And Company Sulfonamide anthelmintics
EP3280716B1 (de) 2015-04-08 2020-02-12 Bayer CropScience AG Imidazo[1,2-a]pyridin-2-yl-derivate als schädlingsbekämpfungsmittel und deren zwischenprodukte
WO2017025419A2 (de) 2015-08-07 2017-02-16 Bayer Cropscience Aktiengesellschaft 2-(het)aryl-substituierte kondensierte heterocyclen-derivate als schädlingsbekämpfungsmittel
PE20181198A1 (es) 2015-10-26 2018-07-23 Bayer Cropscience Ag Derivados de heterociclos biciclicos condensados como agentes de control de plagas
WO2017093180A1 (de) 2015-12-01 2017-06-08 Bayer Cropscience Aktiengesellschaft Kondensierte bicyclische heterocyclen-derivate als schädlingsbekämpfungsmittel
WO2017144341A1 (de) 2016-02-23 2017-08-31 Bayer Cropscience Aktiengesellschaft Kondensierte bicyclische heterocyclen-derivate als schädlingsbekämpfungsmittel
WO2017174414A1 (de) 2016-04-05 2017-10-12 Bayer Cropscience Aktiengesellschaft Naphthalin-derivate als schädlingsbekämpfungsmittel
EP3241830A1 (de) 2016-05-04 2017-11-08 Bayer CropScience Aktiengesellschaft Kondensierte bicyclische heterocyclen-derivate als schädlingsbekämpfungsmittel
CA3031139A1 (en) * 2016-07-19 2018-01-25 Bayer Cropscience Aktiengesellschaft Condensed bicyclic heterocycle derivatives as pest control agents
PE20190800A1 (es) 2016-08-15 2019-06-10 Bayer Cropscience Ag Derivados del heterociclo biciclico condensado como agentes de control de plagas
US10611779B2 (en) 2016-09-19 2020-04-07 Bayer Cropscience Aktiengesellschaft Fused bicyclic heterocycle derivatives as pesticides
WO2018065288A1 (de) 2016-10-07 2018-04-12 Bayer Cropscience Aktiengesellschaft 2-[2-phenyl-1-(sulfonylmethyl)vinyl]-imidazo[4,5-b]pyridin-derivate und verwandte verbindungen als schädlingsbekämpfungsmittel im pflanzenschutz
UY37557A (es) 2017-01-10 2018-07-31 Bayer Ag Derivados heterocíclicos como pesticidas
KR102515694B1 (ko) 2017-01-10 2023-03-29 바이엘 악티엔게젤샤프트 해충 방제제로서의 헤테로사이클 유도체
GB201700692D0 (en) * 2017-01-16 2017-03-01 Salvensis Novel compounds and their use in the treatment of schistosomiasis
WO2018138050A1 (de) 2017-01-26 2018-08-02 Bayer Aktiengesellschaft Kondensierte bicyclische heterocyclen-derivate als schädlingsbekämpfungsmittel
EP3615540B1 (de) 2017-04-24 2022-04-27 Bayer Aktiengesellschaft Kondensierte bicyclische heterocyclen-derivate als schädlingsbekämpfungsmittel
EP3305786A3 (de) 2018-01-22 2018-07-25 Bayer CropScience Aktiengesellschaft Kondensierte bicyclische heterocyclen-derivate als schädlingsbekämpfungsmittel
KR20200122353A (ko) 2018-02-21 2020-10-27 바이엘 악티엔게젤샤프트 해충 방제제로서의 축합 바이시클릭 헤테로시클릭 유도체
WO2020002593A1 (en) 2018-06-29 2020-01-02 Intervet International B.V. Compound for use against helminthic infection
BR112021010400A2 (pt) 2019-02-26 2021-08-24 Bayer Aktiengesellschaft Derivados heterocíclicos bicíclicos condensados como agentes de controle de praga
BR112021010430A2 (pt) 2019-02-26 2021-08-24 Bayer Aktiengesellschaft Derivados de heterociclo bicíclico fundido como pesticidas
PE20220281A1 (es) 2019-03-19 2022-02-25 Boehringer Ingelheim Animal Health Usa Inc Compuestos de aza-benzotiofeno y aza-benzofurano como antihelminticos
CN114846014A (zh) 2019-12-18 2022-08-02 英特维特国际股份有限公司 包含氮杂吲哚结构的驱虫化合物
CN114845994A (zh) 2019-12-18 2022-08-02 英特维特国际股份有限公司 包含喹啉结构的驱虫化合物
IL298596A (en) * 2020-05-29 2023-01-01 Boehringer Ingelheim Animal Health Usa Inc Heterocyclic anthelmintic compounds
GB202019622D0 (en) * 2020-12-11 2021-01-27 Adorx Therapeutics Ltd Antagonist compounds
WO2022122988A1 (en) 2020-12-11 2022-06-16 Intervet International B.V. Anthelmintic compounds comprising a thienopyridine structure

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3725407A (en) * 1971-04-08 1973-04-03 American Cyanamid Co 6-substituted amino-3-nitroimidazo(1,2-b)pyridazines and methods of preparing the same
US3905974A (en) * 1972-09-28 1975-09-16 American Cyanamid Co 6-Substituted oxo and thio-3-nitroimidazo(1,2-b)-pyridazines and methods of preparing same
DD157796A5 (de) 1979-12-04 1982-12-08 Ciba Geigy Ag Verfahren zur herstellung neuer derivate des 2-amino-aethanols

Also Published As

Publication number Publication date
BRPI0418328A (pt) 2007-05-02
ZA200605299B (en) 2007-03-28
ES2285565T3 (es) 2007-11-16
EP1699799A1 (de) 2006-09-13
AU2004312506A1 (en) 2005-07-21
JP2007517043A (ja) 2007-06-28
US20050182059A1 (en) 2005-08-18
CA2551867A1 (en) 2005-07-21
WO2005066177A1 (en) 2005-07-21
NZ548098A (en) 2010-05-28
CN1922181A (zh) 2007-02-28
US7759349B2 (en) 2010-07-20
DE602004006536T2 (de) 2008-01-31
ATE362475T1 (de) 2007-06-15
JP4758909B2 (ja) 2011-08-31
CA2551867C (en) 2010-08-17
KR20060110344A (ko) 2006-10-24
AU2004312506B2 (en) 2011-08-04
CN100582108C (zh) 2010-01-20
EP1699799B1 (de) 2007-05-16
HK1091207A1 (en) 2007-01-12
PL380764A1 (pl) 2007-03-19

Similar Documents

Publication Publication Date Title
DE602004006536D1 (de) Bekämpfng von parasiten in tieren durch anwendung von imidazoä1,2-büpyridazinderivaten
MX2007006072A (es) Control de parasitos en animales mediante el uso de derivados del parasiticida 2-fenil-3-(1h-pirrol-2-il)acrilonitrilo.
DK1333833T3 (da) Ny trisubstitueret 8H-pyridol[2,3-d]pyrimidin-7-on-forbindelse til behandling af CSBP/RK/p38-kinnasemedierede sygdomme
NO20054082L (no) Pyrazol`1,5-A! 1,3,5! triazinderivater som kannabinoidreseptorligander
WO2005048948A3 (en) Urea derivatives as kinase modulators
WO2006034333A3 (en) Control of parasites in animals by the use of novel trifluoromethanesulfonanilide oxime ether derivatives
BR0014352A (pt) Cetoenóis espirocìclicos substituìdos por trifluormetila
DK1215965T3 (da) Fremgangsmåde og præparat til bekæmpelse af arthropoder
DE602004005073D1 (de) Verbesserte kosmetische zusammensetzung mit vitamin b3, vitamin b6 und einer organischen säure
CY1106766T1 (el) Παραγωγα πυριδινης ως αναστολεις raf κινασης
DK1864975T3 (da) Nikotinamid-derivater anvendelige som P38-inhibitorer
DE602006016760D1 (de) Zusammensetzungen und verfahren zur kontrolle, prävention und behandlung von essstörungen
WO2005040169A3 (en) Fused heterocyclic compounds as serotonin receptor modulators
NO20043130L (no) Surgjorende stimuleringsmetode ved anvendelse av pH bufferet syrelosning
ATE451376T1 (de) Zusammensetzungen, die sich als inhibitoren von proteinkinasen eignen
PE20020521A1 (es) Compuestos heterociclicos sustituidos para tratar la resistencia a multiples drogas
DE502004002571D1 (de) Substituierte 3-pyrrolidin-indol-derivate
ATE380813T1 (de) Imidazopyridinsubstituierte tropanderivate mit ccr5-rezeptorantagonistischer wirkung zur behandlung von hiv und entzündungen
ATE389651T1 (de) Als inhibitoren von c-met geeignete pyrrolzusammensetzungen
DE60228073D1 (de) Adenosin-a1-rezeptorantagonisten zur behandlung von hypoxiebedingten lern- und gedächtnisstörungen
DE60304695D1 (de) 7-ARYLSULFONAMID-2,3,4,5-TETRAHYDRO-1H-BENZOiDöAZEPINE MIT 5-HT6 REZEPTOR AFFINITÄT ZUR BEHANDLUNG VON ZENTRALNERVENSYSTEMERKRANKUNGEN
WO2004043379A3 (en) Chemical compounds
DE60206289D1 (de) Verwendung von bibn4096 in kombination mit anderen migränemitteln zur behandlung von migräne
DE50205466D1 (de) Substituierte 2,5-diamidoindole als ece-inhibitoren zur behandlung von kardiovaskulären erkrankungen
WO2004034985A3 (en) Chemical compounds

Legal Events

Date Code Title Description
8364 No opposition during term of opposition